Development and validation of TLC densitometry method for the determination of Gliclazide in tablet dosage form

Authors

  • Yuni Retnaningtyas Reseach and Development centre in Laboratory of Chemical Pharmacy University of Jember, East Java
  • Lestyo Wulandari Reseach and Development centre in Laboratory of Chemical Pharmacy University of Jember, East Java
  • Feby Erliana Reseach and Development centre in Laboratory of Chemical Pharmacy University of Jember, East Java

DOI:

https://doi.org/10.3329/icpj.v1i10.11852

Keywords:

Gliclazide, TLC, Validation

Abstract

Some tablet pharmaceutical preparations containing Gliclazide as sole active ingredient, are marked now in Indone-sia. The determination of the component of preparation both qualitatively and quantitatively is important to ensure quality of the product. This research is aimed to develop a TLC method to analyze gliclazide in its single component tablet formulation. Gliclazide were dissolved with chloroform. Gliclazide was chromatographed on silica Gel 60 F254 TLC plate using toluene: ethyl acetate in the ratio of 1:1 (v/v) as mobile phase. Gliclazide showed Rf value of 0.58 and was scanned at 234nm using Camag TLC Scanner 3. This method validation showed a good linearity with correlation coefficient (r) of 0.999 while the coefficient of variation of the regression function (Vx0) = 2.406%. Specificity showed calculation of purity and identity more than 0.99. The limit of detection (LOD) and the limit of quantification (LOQ) of the method was respectively 28.78 and 86.35 ng/spot respectively. The mean absolute recovery of Gliclazide from the simulation  sample was  100.5% ± 0.113 and the method precision was less than  5.3% whereas the mean of the recovery data was 100.3%. The proposed method has been applied to the determination of Gliclazide in commercial tablet formulations and the recovery of label claim were100.494%±0.348 for brand A and 100.111%±1.257% for brand B.  The developed method was successfully used for the assay of gliclazide. The method is simple, sensitive and precise; it can be used for the routine quality control testing of marketed formulations.

DOI: http://dx.doi.org/10.3329/icpj.v1i10.11852

International Current Pharmaceutical Journal 2012, 1(10): 332-335

Downloads

Download data is not yet available.
Abstract
654
PDF
1337

Downloads

Published

2012-09-05

How to Cite

Retnaningtyas, Y., Wulandari, L., & Erliana, F. (2012). Development and validation of TLC densitometry method for the determination of Gliclazide in tablet dosage form. International Current Pharmaceutical Journal, 1(10), 332–335. https://doi.org/10.3329/icpj.v1i10.11852

Issue

Vol. 1 No. 10 (2012)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).